0001140361-14-001804.txt : 20140110 0001140361-14-001804.hdr.sgml : 20140110 20140110172155 ACCESSION NUMBER: 0001140361-14-001804 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140101 FILED AS OF DATE: 20140110 DATE AS OF CHANGE: 20140110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTRX CORP CENTRAL INDEX KEY: 0000799698 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581642750 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 BUSINESS PHONE: 310-826-5648 MAIL ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVITT DANIEL J CENTRAL INDEX KEY: 0001278711 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-15327 FILM NUMBER: 14522636 MAIL ADDRESS: STREET 1: C/O DYNAVAX TECHNOLOGIES CORP STREET 2: 2929 SEVENTH ST STE 100 CITY: BERKELEY STATE: CA ZIP: 94710 4/A 1 doc1.xml FORM 4/A X0306 4/A 2014-01-01 2014-01-03 0 0000799698 CYTRX CORP CYTR 0001278711 LEVITT DANIEL J 11726 SAN VICENTE BLVD. LOS ANGELES CA 90049 0 1 0 0 EVP and Chief Medical Officer Common Stock 2014-01-01 4 A 0 100000 0 A 157983 D A subsequent review by CytRx disclosed that the amount of common stock shares reacquired by the company to satisfy Mr. Levitt's California state tax obligations should be reduced by 277, and likewise the amount of shares beneficially owned by him increased by an equivalent amount, from 157,706 as previously reported, to 157,983. Daniel J. Levitt 2014-01-10